Deep Dives
+2
Sep 26, 2025
•
31 min read
How a physician rollup became the first test of the “Extend-and-Exchange” LME
Sep 19, 2025
3 min read
How the Pharmaceutical Enron restructuring solved the near-term debt wall, but the endgame is still uncertain
Jun 27, 2025
7 min read
How insurance fraud dragged an unconventional software rollup into Chapter 11
+4
May 2, 2025
10 min read
A litigation-riddled company, challenges in healthcare regulations, and the fascinating dynamic of insider structures within a Chapter 11 bankruptcy.
Jan 10, 2025
Overview of Rite Aid, Signs of Distress, Alternatives to Chapter 11, 2.0 Plan, 363 Asset Sale of Elixir, and many more topics
Healthcare
+1
Jan 3, 2025
14 min read
Key Players, The Unit Economics of a Pharmacy, Comparison of Business Models, Factors Behind Financial Distress, Solutions to Address Liquidity Crunch
Sep 13, 2024
8 min read
In the article below, we will cover this industry: its origins, major players, market performance, key criticisms, and much more. This is a fascinating sector that most of us rarely interact with.
Mar 29, 2024
5 min read
If you bought Danaher stock in 1984, you would have returned 192,208%
Oct 27, 2023
Diving deep into YesCare and its unique Texas Two Step restructuring
